The Korean Version of Skindex-29

피부과 환자의 삶의 질 평가를 위한 한국어판 Skindex-29

Ahn, Bong-Kyun;Lee, Sang-Ju;Namkoong, Ki;Chung, Yae-Lee;Lee, Seung-Hun
안봉균;이상주;남궁기;정예리;이승헌

  • Published : 20040100

Abstract

Background: Most available dermatologic quality-of-life measures were written in English. So these must be translated for use in Korea. Our purpose was to translate and adapt culturally into Korean a skin-related quality-of-life measure Skindex-29, and to begin preliminary assessments of its reliability and validity. Methods: Cross-cultural adaptation questionnaire studies were performed. Two hundred and sixty adult outpatients and healthy people responded to the Korean version of Skindex-29. Evaluations of the semantic equivalence of back-translated items, reliability, construct validity, and content validity of the Korean version were the main outcome measures. Comparison between the Korean version and other versions of Skindex-29 (Spanish and American) responses was also performed, Results: Five problematic items required a second translation and back-translation to achieve satisfactory agreement with the original instrument. The final Korean version of Skindex-29 was internally reliable. The instrument demonstrated both construct and content validity. As hypothesized, scores for dermatologic patients were higher than those of healthy persons and scores for patients with inflammatory diseases were higher than those of persons with isolated skin lesions. Skindex scale scores of the Korean version and other versions of Skindex-29 were similar. Conclusions: We have developed a semantically equivalent translation of Skindex-29 in Korean. Our preliminary evaluation of its measurement properties suggests that it is a reliable and valid measure of the effects of skin disease on the quality of life in Korean patients.

Keywords

References

  1. Jones-Caballero M, Penas PF, Garcia-Diez A, Badia X, Chren MM. The Spanish version of Skindex-29. Cultural adaptation and preliminary evidence of validity and equivalence with the original American version. Int J Dermatol 2000; 39:907-912 https://doi.org/10.1046/j.1365-4362.2000.00944.x
  2. Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM. Further evidence of the validity and reliability of the Skindex-29: An Italian study on 2,242 dermatological outpatients. Dermatology 2002; 204:43-49 https://doi.org/10.1159/000051809
  3. Schmidt S, Fischer TW, Chren MM, Strauss BM, Elsner P. Strategies of coping and quality of life in women with alopecia. Br J Dermatol 2001;144:1038-1043 https://doi.org/10.1046/j.1365-2133.2001.04195.x
  4. Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A. Quality of life impairment in neurofibromatosis type 1. Arch Dermatol 2001;137:1421-1430
  5. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417-1432 https://doi.org/10.1016/0895-4356(93)90142-N
  6. Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg 1998;17:291-296 https://doi.org/10.1016/S1085-5629(98)80026-6
  7. Mckenna KE, Stem RS. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol 1996 ;34:534-538 https://doi.org/10.1016/S0190-9622(96)90469-7
  8. Finlay AY. The outcomes movement and new measures of psoriasis. J Am Acad Dermatol 1997 ;36:502-503
  9. Jemec GB, Wulf HC. Patient-physician consensus on quality of life in dermatology. Clin Exp Dermatol 1996;21:177-179 https://doi.org/10.1111/j.1365-2230.1996.tb00057.x
  10. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996 ;107:707-713 https://doi.org/10.1111/1523-1747.ep12365600
  11. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997 ;133:1433-1440 https://doi.org/10.1001/archderm.133.11.1433
  12. Hunt SM, Alonso J, Bucquet D, Niero M, Wiklund I, McKenna S. Cross-cultural adaptation of health measures. European Group for Health Management and Quality of Life Assessment. Health Policy. 1991 ;19:33-44 https://doi.org/10.1016/0168-8510(91)90072-6
  13. Shuster S, Fisher G, Harris E, Binnell D. The effects of skin disease on self-image. Br J Dermatol 1978; 99:18-19
  14. Jowett S & Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985; 20: 425-429 https://doi.org/10.1016/0277-9536(85)90021-8
  15. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987;17:25-32 https://doi.org/10.1016/S0190-9622(87)70166-2
  16. Wu SF, Kinder BN, Trunnell TN, Fulton JE. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J Am Acad Dermatol. 1988;18:325-333 https://doi.org/10.1016/S0190-9622(88)70047-X
  17. Lucas CJ. Personality of students with acne vulgaris. BMJ 1961;2:354 https://doi.org/10.1136/bmj.2.5248.354
  18. Wittkower E. Acne vulgaris: a psychosomatic study. Br J Dermatol 1951;63:214-223 https://doi.org/10.1111/j.1365-2133.1951.tb13715.x
  19. Krowchuk DP, Stancin T, Keskinen R, Walker R, Bass J, Anglin TM. The psychosocial effects of acne on adolescents. Pediatr Dermatol 1991;8:332-338 https://doi.org/10.1111/j.1525-1470.1991.tb00945.x
  20. Myhill JE, Leichttnan SR, Burnett JW. Self-esteem and social assertiveness in patients receiving isotretinoin treatment for cystic acne. Cutis 1988;41:171-173
  21. Schachter RJ, Pantel ES, Glassman GM, Zweibelson I. Acne vulgaris and psychologic impact on high school students. N Y State J Med 1971;71:2886-2890
  22. Van der Meeren HLM, van der Schaar WW, van den Hurk CMAM. The psychological impact of severe acne. Cutis. 1985;36:84-86